Fisher & Paykel Healthcare can’t predict the future

Fisher & Paykel Healthcare can’t predict the future
Chief executive Lewis Gradon told analysts there was a big opportunity ahead but couldn't say when the company would reach it. (Photo: Supplied)
Dan Brunskill
Medical device manufacturer Fisher & Paykel Healthcare is unquestionably in a better position than it was pre-covid, the question everyone is asking is: how much better? It was a question that not even chief executive Lewis Gradon was able to answer when asked by analysts after reporting earnings on Wednesday. The company declined to give earnings guidance for the third straight year, saying it was too hard to predict how much stock customers would want to hold and the possibility of future covid-19 surges.Unable to give guidance,...

More Markets

Westpac looks seaward to boost NZ's economy
Primary Sector

Westpac looks seaward to boost NZ's economy

A senior scientist says less red tape could transform the aquaculture industry.

Fletcher Building cuts more than 500 jobs
Infrastructure

Fletcher Building cuts more than 500 jobs

Fletcher is overachieving in cost cutting, managing director Andrew Reding says.

‘I want to get my life back’: Ebos’ John Cullity
Markets

‘I want to get my life back’: Ebos’ John Cullity

He's ‘had a great run’, but the Ebos CEO says it’s time to recalibrate and reset.

NZ sharemarket dips as interest rates cut
Markets Market Close

NZ sharemarket dips as interest rates cut

The S&P/NZX 50 Index closed at 13,033.36, down 17.76 points or 0.14%.

Staff reporters 19 Feb 2025